Broad Institute-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2012

  1. Temporal molecular and biological assessment of an erlotinib-resistant lung adenocarcinoma model reveals markers of tumor progression and treatment response

    Cancer Research, Vol. 72, Núm. 22, pp. 5921-5933